New advances in juvenile spondyloarthritis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22487801.
- Also identified by DOI 10.1038/nrrheum.2012.37.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Juvenile spondyloarthritis (SpA) is a distinct disease to adult SpA, and usually manifests as peripheral arthritis and enthesitis. Importantly, many patients with juvenile SpA continue to be at risk of developing ankylosing spondylitis during their disease course. In this Review, the classification and diagnostic criteria, clinical manifestations and treatment guidelines for juvenile SpA will be discussed. Advances in the diagnosis of and management strategies for juvenile SpA will lead to earlier recognition, appropriate treatment and improved rates of inactive disease, which should lead to improved patient outcomes and quality of life.
Medical subject headings
- Diagnostic Imaging
- Radiographic Image Enhancement
- Spondylarthritis
- Tumor Necrosis Factor-alpha